Geißler R Georg, Franz Dominik, Buddendick Hubert, Krakowitzky Petra, Bunzemeier Holger, Roeder Norbert, Van Aken Hugo, Kessler Torsten, Berdel Wolfgang, Sibrowski Walter, Schlenke Peter
Institute for Transfusion Medicine and Transplantation Immunology, Germany.
Transfus Med Hemother. 2012 Apr;39(2):129-138. doi: 10.1159/000337956. Epub 2012 Mar 22.
Demographic data illustrate clearly that people in highly developed countries get older, and the elderly need more blood transfusions than younger patients. Additionally, special extensive therapies result in an increased consumption of blood components. Beyond that the aging of the population reduces the total number of preferably young and healthy blood donors. Therefore, Patient Blood Management will become more and more important in order to secure an increasing blood supply under fair-minded conditions. METHODS: At the University Hospital of Münster (UKM) a comprehensive retrospective analysis of the utilization of all conventional blood components was performed including all medical and surgical disciplines. In parallel, a new medical reporting system was installed to provide a monthly analysis of the transfusional treatments in the whole infirmary, in every department, and in special blood-consuming cases of interest, as well. RESULTS: The study refers to all UKM in-patient cases from 2009 to 2011. It clearly demonstrates that older patients (>60 years, 35.2-35.7% of all cases, but 49.4-52.6% of all cases with red blood cell (RBC) transfusions, 36.4-41. 6% of all cases with platelet (PTL, apheresis only) transfusions, 45.2-48.0% of all cases with fresh frozen plasma (FFP) transfusions) need more blood products than younger patients. Male patients (54.4-63.9% of all cases with transfusions) are more susceptible to blood transfusions than female patients (36.1-45.6% of all cases with transfusions). Most blood components are used in cardiac, visceral, and orthopedic surgery (49.3-55.9% of all RBC units, 45.8-61.0% of all FFP units). When regarding medical disciplines, most transfusions are administered to hematologic and oncologic patients (12.9-17.7% of all RBC units, 9.2-12.0% of all FFP units). The consumption of PTL in this special patient cohort (40.6-50.9% of all PTL units) is more pronounced than in all other surgical or in non-surgical disciplines. CONCLUSION: The results obtained from our retrospective analysis may help to further optimize the responsible and medical indication-related utilization of blood transfusions as well as the recruitment of blood donors and their timing. It may be also a helpful tool in order to avoid needless transfusions and transfusionassociated adverse events.
人口统计学数据清楚地表明,高度发达国家的人口老龄化,老年人比年轻患者需要更多的输血。此外,特殊的广泛治疗导致血液成分的消耗增加。除此之外,人口老龄化减少了年轻且健康的首选献血者总数。因此,为了在公平的条件下确保不断增加的血液供应,患者血液管理将变得越来越重要。
在明斯特大学医院(UKM),对所有常规血液成分的使用情况进行了全面的回顾性分析,涵盖所有医学和外科学科。同时,安装了一个新的医疗报告系统,以每月分析整个医院、每个科室以及特殊的高用血病例中的输血治疗情况。
该研究涉及2009年至2011年UKM的所有住院病例。结果清楚地表明,老年患者(>60岁,占所有病例的35.2 - 35.7%,但在所有接受红细胞(RBC)输血的病例中占49.4 - 52.6%,在所有接受血小板(PTL,仅单采)输血的病例中占36.4 - 41.6%,在所有接受新鲜冰冻血浆(FFP)输血的病例中占45.2 - 48.0%)比年轻患者需要更多的血液制品。男性患者(在所有输血病例中占54.4 - 63.9%)比女性患者(在所有输血病例中占36.1 - 45.6%)更容易接受输血。大多数血液成分用于心脏、内脏和骨科手术(占所有RBC单位的49.3 - 55.9%,占所有FFP单位的45.8 - 61.0%)。就医学学科而言,大多数输血用于血液学和肿瘤学患者(占所有RBC单位的12.9 - 17.7%,占所有FFP单位的9.2 - 12.0%)。在这个特殊患者群体中血小板的消耗量(占所有血小板单位的40.6 - 50.9%)比所有其他外科或非外科科室更为显著。
我们的回顾性分析结果可能有助于进一步优化输血的合理使用及与医学指征相关的使用,以及献血者的招募和献血时机。它也可能是避免不必要输血及输血相关不良事件的有用工具。